Aethlon Medical, Inc. (AEMD)

NASDAQ: AEMD · IEX Real-Time Price · USD
1.66 0.01 (0.61%)
Jan 25, 2022 3:59 PM EST - Market closed
Market Cap25.56M
Revenue (ttm)923,036
Net Income (ttm)-8.81M
Shares Out15.40M
EPS (ttm)-0.64
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,385
Open1.63
Previous Close1.65
Day's Range1.60 - 1.70
52-Week Range1.45 - 12.49
Beta0.49
AnalystsBuy
Price Target9.33 (+462.0%)
Earnings DateFeb 8, 2022

About AEMD

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pitts...

IndustryHealth Care Equipment & Supplies
CEOTimothy Rodell
Employees10
Stock ExchangeNASDAQ
Ticker SymbolAEMD
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for AEMD stock is "Buy" and the 12-month stock price forecast is 9.33.

Price Target
$9.33
(462.05% upside)
Analyst Consensus: Buy

News

Alzamend Neuro Announces Positive Topline Data from Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Deme...

TAMPA, Fla.--(BUSINESS WIRE)---- $AEMD #505B2--Alzamend Neuro Announces Positive Topline Data from Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer's

1 month ago - Business Wire

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 9, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today reported financial r...

2 months ago - PRNewsWire

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021

SAN DIEGO, Nov. 2, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it wil...

2 months ago - PRNewsWire

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated w...

SAN DIEGO, Oct. 12, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced the public...

3 months ago - PRNewsWire

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

SAN DIEGO, Sept. 30,  2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it ...

3 months ago - PRNewsWire

8 Things to Know About Aethlon Medical as Investors Send AEMD Stock Soaring Today

Aethlon Medical (AEMD) stock is rising higher on Wednesday due to heavy trading despite a lack of news from the company. The post 8 Things to Know About Aethlon Medical as Investors Send AEMD Stock Soar...

4 months ago - InvestorPlace

Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

SAN DIEGO, Sept. 7, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, toda...

4 months ago - PRNewsWire

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 9, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today...

5 months ago - PRNewsWire

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021

SAN DIEGO, July 29, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial r...

5 months ago - PRNewsWire

This Is Why Stocks Are Down Today

Stocks begin week with the market selling off; why? The post This Is Why Stocks Are Down Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:AHPINVAXOGEN
6 months ago - PennyStocks

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

SAN DIEGO, June 24, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, toda...

7 months ago - PRNewsWire

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

SAN DIEGO, June 21, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial r...

7 months ago - PRNewsWire

Why Aethlon Medical's Stock Is Plunging Today

After surging 400% yesterday, Aethlon Medical, Inc. (NASDAQ: AEMD) shares are trading lower after the company announced a 1.38-million share registered direct offering priced at $9 per share. The gross ...

7 months ago - Benzinga

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, June 10, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), a medical device technology company focused on unmet needs in global health, today announced that it has entered into a defi...

7 months ago - PRNewsWire

Aethlon Medical stock explodes 465% on heavy volume as new report about COVID-19 treatment inspires social-media disc...

Shares of Aethlon Medical exploded as much as 465% to a two-year high on Wednesday despite not releasing any news since last week, when one of its devices showed positive results in two COVID-19 patient...

7 months ago - Business Insider

AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 350%+

Shares of AEMD stock are taking off on Wednesday following the firm's June 3 report of its coronavirus treatment returning promising results. The post AEMD Stock: The Historic Covid-19 News Sending Aeth...

7 months ago - InvestorPlace

Aethlon Medical stock more than quadruples on heavy volume

Shares of Aethlon Medical Inc. skyrocketed more than fourfold on massive volume toward a two-year high in morning trading Wednesday, even though the California-based therapeutic technology company hasn'...

7 months ago - Market Watch

Why Aethlon Medical Stock Skyrocketing?

Aethlon Medical Inc (NASDAQ: AEMD) stock surged probably in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient.' The company recently anno...

7 months ago - Benzinga

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

SAN DIEGO, June 3, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print ...

7 months ago - PRNewsWire

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

SAN DIEGO, March 1, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will particip...

10 months ago - PRNewsWire

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

SAN DIEGO, Feb. 4, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial re...

11 months ago - PRNewsWire

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer

SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, tod...

1 year ago - PRNewsWire

Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference

SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, tod...

1 year ago - PRNewsWire

Aethlon Medical News Alert: Why AEMD Stock Is Rocketing Higher Today

Aethlon Medical (AEMD) news for Wednesday concerning the progress in an EFS for one of its medical devices has AEMD stock soaring higher. The post Aethlon Medical News Alert: Why AEMD Stock Is Rocketing...

1 year ago - InvestorPlace

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D.

SAN DIEGO, Nov. 3, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, annou...

1 year ago - PRNewsWire